As SEPT9 and SEPT2 knockdowns suppressed the GBM cell growth in a synergistic manner, we speculate that overexpression of one Septin gene could compensate for the loss of another in GBM cells. The gene discussed is SEPTIN2; the disease is glioblastoma.